Form 4 for EW Edwards Lifesciences
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001225208-23-005919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | EW | Wood Larry L | Gbl Pres TAVR, Surg | A - Grant | $0.00 | +7,775 | 213.8K | +4% | $0 |
| DM | 2023-05-15 | 2023-05-11 | EW | Wood Larry L | Gbl Pres TAVR, Surg | A - Grant | $0.00 | +75.4K | 65.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | A | A | 7,775 | $0.00 | 213,793.71 | D | — | — | (F1) These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. (F2) Reflects shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person. |
| 2 | Derivative | Performance Rights | 2023-05-11 | A | A | 9,725 | $0.00 | 9,725 | D | — · 2026-05-11 to — | 9,725 Common Stock | (F4) Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-05-11 | A | A | 65,700 | $0.00 | 65,700 | D | $88.78 · 2024-05-11 to 2030-05-10 | 65,700 Common Stock | (F3) These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. |